4//SEC Filing
Horizon Pharma plc 4
Accession 0001209191-16-135891
CIK 0001492426operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:45 PM ET
Size
9.1 KB
Accession
0001209191-16-135891
Insider Transaction Report
Form 4
HAMPTON GEORGE P
See remarks
Transactions
- Tax Payment
Ordinary Shares
2016-08-05$20.10/sh−5,129$103,093→ 21,335 total - Exercise/Conversion
Restricted Stock Units
2016-08-05−18,750→ 56,250 total→ Ordinary Shares (18,750 underlying) - Exercise/Conversion
Ordinary Shares
2016-08-05+18,750→ 26,464 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Includes 1,537 ordinary shares of the Issuer acquired by the reporting person on June 1, 2016 pursuant to an employee stock purchase program.
- [F3]On August 5, 2015, the reporting person was granted an aggregate of 75,000 restricted stock units. The restricted stock units vest in four equal annual installments beginning on August 5, 2016.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:45 PM ET
- Size
- 9.1 KB